MarketPeel
EVP R&D, Chief Medical Officer
Thu, Jan 8, 2026
Jan 8
exercised or converted securities in ALKS
5,000 shares @ $0.00
Decreased holdings by -13.80%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-1.23%
1M-7.60%
3M+28.30%
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback